SG Americas Securities
KYNB

SG Americas Securities’s Kyntra Bio KYNB Stock Holding History

SG Americas Securities’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,310
Closed -$77K – 2996
2024
Q1 		$77K Sell
1,310
-3,201
-71% -$138K ﹤0.01% 2628
2023
Q4 		$100K Buy
4,511
+2,003
+80% +$30.2K ﹤0.01% 2766
2023
Q3 		$54K Buy
2,508
+2,089
+499% +$82K ﹤0.01% 2921
2023
Q2 		$28K Sell
419
-2,210
-84% -$914K ﹤0.01% 2164
2023
Q1 		$1.23M Buy
2,629
+1,305
+99% +$690K 0.01% 1008
2022
Q4 		$530K Sell
1,324
-378
-22% -$145K 0.01% 1484
2022
Q3 		$554K Sell
1,702
-626
-27% -$202K 0.01% 1463
2022
Q2 		$615K Buy
2,328
+1,641
+239% +$419K 0.01% 1770
2022
Q1 		$206K Sell
687
-865
-56% -$302K ﹤0.01% 2413
2021
Q4 		$547K Sell
1,552
-960
-38% -$299K ﹤0.01% 2113
2021
Q3 		$642K Buy
2,512
+1,338
+114% +$474K ﹤0.01% 2290
2021
Q2 		$782K Sell
1,174
-968
-45% -$558K ﹤0.01% 1705
2021
Q1 		$1.86M Sell
2,142
-1,218
-36% -$1.3M 0.01% 1093
2020
Q4 		$3.12M Buy
3,360
+1,809
+117% +$1.9M 0.02% 797
2020
Q3 		$1.59M Sell
1,551
-969
-38% -$1.04M 0.01% 894
2020
Q2 		$2.55M Buy
2,520
+1,787
+244% +$1.66M 0.02% 678
2020
Q1 		$637K Buy
733
+203
+38% +$202K 0.01% 1639
2019
Q4 		$568K Buy
530
+121
+30% +$124K 0.01% 1664
2019
Q3 		$378K Sell
409
-100
-20% -$110K ﹤0.01% 2035
2019
Q2 		$575K Buy
509
+58
+13% +$63.5K ﹤0.01% 1795
2019
Q1 		$613K Buy
451
+208
+86% +$282K 0.01% 1658
2018
Q4 		$281K Buy
+243
New +$273K ﹤0.01% 2213
2018
Q3 		– Sell
-164
Closed -$257K – 3248
2018
Q2 		$257K Sell
164
-250
-60% -$326K ﹤0.01% 2439
2018
Q1 		$478K Sell
414
-607
-59% -$799K ﹤0.01% 1902
2017
Q4 		$1.21M Buy
1,021
+461
+82% +$578K 0.01% 1233
2017
Q3 		$754K Buy
560
+290
+107% +$306K 0.01% 1476
2017
Q2 		$218K Buy
270
+17
+7% +$11.8K ﹤0.01% 2362
2017
Q1 		$156K Sell
253
-699
-73% -$426K ﹤0.01% 2630
2016
Q4 		$509K Buy
952
+476
+100% +$238K ﹤0.01% 1689
2016
Q3 		$246K Buy
+476
New +$224K ﹤0.01% 2310
2015
Q4 		– Sell
-310
Closed -$170K – 2786
2015
Q3 		$170K Buy
+310
New +$188K ﹤0.01% 1550

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

SG Americas Securities's KYNB Position: Q2 2024 in Review

SG Americas Securities sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 1,310 shares — an estimated $77K sold.

SG Americas Securities first reported a position in KYNB in Q3 2015 and held it in 31 quarters. The position peaked at $3.12M in Q4 2020. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • SG Americas Securities reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • SG Americas Securities sold 1,310 Kyntra Bio shares in Q2 2024, an estimated $77K.
  • SG Americas Securities first reported a position in Kyntra Bio in Q3 2015 and held it in 31 quarters.
  • SG Americas Securities's Kyntra Bio position peaked at $3.12M in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.